Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Works of Neelima Vidula being referenced
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer
2022
Novel antibody–drug conjugates for triple negative breast cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Neelima Vidula | 456 | 306 | 190 | 66 | 677 | |
| Fara Brasó‐Maristany | 442 | 273 | 269 | 59 | 656 | |
| Akshara Singareeka Raghavendra | 483 | 300 | 243 | 69 | 791 | |
| Reshma Mahtani | 410 | 215 | 182 | 75 | 592 | |
| Noelia Martínez-Jáñez | 548 | 285 | 303 | 75 | 805 | |
| Samanta Sarti | 473 | 187 | 201 | 46 | 770 | |
| Olga Martínez‐Sáez | 434 | 326 | 283 | 60 | 778 | |
| Claudia Andreetta | 501 | 200 | 291 | 41 | 795 | |
| Silvia P. Neciosup | 393 | 194 | 226 | 45 | 690 | |
| G. Thomas Budd | 445 | 263 | 134 | 39 | 701 | |
| Erica Stringer-Reasor | 370 | 212 | 253 | 46 | 688 |
All Works
Login with ORCID to disown or claim papers
Loading papers...